FindTrial
Sign In

To Compare effect of hyperbaric 0.75% ropivacaine and hyperbaric 0.5% bupivacaine in terms of sensory and motor effect characteristics

COMPARING BLOCK CHARACTERISTICS BETWEEN HYPERBARIC 0.75% ROPIVACAINE AND HYPERBARIC 0.5% BUPIVACAINE FOR SURGERIES UNDER SPINAL ANAESTHESIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046587
Enrollment
124
Registered
2022-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Hyperbaric ropivacaine in spinal anaesthesia: Giving 2.8ml of 0.75% hyperbaric ropivacaine for surgeries under spinal anaesthesia Control Intervention1: Hyperbaric bupivacaine in spinal

Sponsors

Maulana Azad medical College and associated hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I/II Age 18-60 years BMI less than 30 kg/m2 Height 152cm to 182cm

Exclusion criteria

Exclusion criteria: Pregnant patients Hepatic, Cardiovascular or renal dysfunction Neuromuscular disorders Contraindications to spinal anaesthesia Any allergy to study medications

Design outcomes

Primary

MeasureTime frame
Duration of sensory block Timepoint: 12 months—

Secondary

MeasureTime frame
Onset time of sensory block Time to Maximum sensory block Duration of 2 segment regression of sensory blockade from maximum block Duration of motor block Timepoint: 12 months—

Countries

India

Contacts

Public Contactsurbhi goswami

Maulana Azad Medical College

Kirtinath@gmail.com9968604215

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026